Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luc Vanhamme

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Infectious Disorders Drug Targets|May 1, 2010
The human trypanolytic factor: a drug shaped naturallyLuc Vanhamme
Current Drug Targets|November 11, 2008
Trypanosome RNA polymerases and transcription factors: sensible trypanocidal drug targets?Luc Vanhamme
International Journal for Parasitology|June 26, 2004
The trypanosome lytic factor of human serum and the molecular basis of sleeping sicknessLuc Vanhamme, Etienne Pays
Proceedings of the National Academy of Sciences of the United States of America|June 4, 2014
Transcription is initiated on silent variant surface glycoprotein expression sites despite monoallelic expression in Trypanosoma bruceiAli Kassem, Etienne Pays, Luc Vanhamme
Current Opinion in Microbiology|August 4, 2004
Antigenic variation in Trypanosoma brucei: facts, challenges and mysteriesEtienne Pays, Luc Vanhamme, David Pérez-Morga
Sleep Medicine Reviews|August 13, 2011
Immune, inflammatory and cardiovascular consequences of sleep restriction and recoveryBrice Faraut, Karim Zouaoui Boudjeltia, Luc Vanhamme, et al.
Pathogens (Basel, Switzerland)|November 26, 2020
The Functional Parasitic Worm Secretome: Mapping the Place of <i>Onchocerca volvulus</i> Excretory Secretory ProductsLuc Vanhamme, Jacob Souopgui, Stephen Ghogomu, et al.
Archives of Biochemistry and Biophysics|April 4, 2018
The other myeloperoxidase: Emerging functionsLuc Vanhamme, Karim Zouaoui Boudjeltia, Pierre Van Antwerpen, et al.
Experimental Parasitology|February 17, 2005
Trypanosoma brucei: growth differences in different mammalian sera are not due to the species-specificity of transferrinDidier Salmon, Françoise Paturiaux-Hanocq, Philippe Poelvoorde, et al.
Mediators of Inflammation|August 29, 2013
Low-density lipoprotein modified by myeloperoxidase in inflammatory pathways and clinical studiesCédric Delporte, Pierre Van Antwerpen, Luc Vanhamme, et al.
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Infectious Disorders Drug Targets|May 1, 2010
The human trypanolytic factor: a drug shaped naturallyLuc Vanhamme
Current Drug Targets|November 11, 2008
Trypanosome RNA polymerases and transcription factors: sensible trypanocidal drug targets?Luc Vanhamme
International Journal for Parasitology|June 26, 2004
The trypanosome lytic factor of human serum and the molecular basis of sleeping sicknessLuc Vanhamme, Etienne Pays
Proceedings of the National Academy of Sciences of the United States of America|June 4, 2014
Transcription is initiated on silent variant surface glycoprotein expression sites despite monoallelic expression in Trypanosoma bruceiAli Kassem, Etienne Pays, Luc Vanhamme
Current Opinion in Microbiology|August 4, 2004
Antigenic variation in Trypanosoma brucei: facts, challenges and mysteriesEtienne Pays, Luc Vanhamme, David Pérez-Morga
Sleep Medicine Reviews|August 13, 2011
Immune, inflammatory and cardiovascular consequences of sleep restriction and recoveryBrice Faraut, Karim Zouaoui Boudjeltia, Luc Vanhamme, et al.
Pathogens (Basel, Switzerland)|November 26, 2020
The Functional Parasitic Worm Secretome: Mapping the Place of <i>Onchocerca volvulus</i> Excretory Secretory ProductsLuc Vanhamme, Jacob Souopgui, Stephen Ghogomu, et al.
Archives of Biochemistry and Biophysics|April 4, 2018
The other myeloperoxidase: Emerging functionsLuc Vanhamme, Karim Zouaoui Boudjeltia, Pierre Van Antwerpen, et al.
Experimental Parasitology|February 17, 2005
Trypanosoma brucei: growth differences in different mammalian sera are not due to the species-specificity of transferrinDidier Salmon, Françoise Paturiaux-Hanocq, Philippe Poelvoorde, et al.
Mediators of Inflammation|August 29, 2013
Low-density lipoprotein modified by myeloperoxidase in inflammatory pathways and clinical studiesCédric Delporte, Pierre Van Antwerpen, Luc Vanhamme, et al.
Pageof 9